OUTLOOK THERAPEUTICS
Live / Applied — Fifth extension granted (statement of use) (as of 12 Mar 2026)
What this means for you
Not registered yet, but its 27 Jun 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97478024
- Mark type
- Stylized text
- Filed
- 27 Jun 2022
- Published for opposition
- 16 May 2023
- Attorney of record
- Kelley B. Harrington
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals, namely, ophthalmic drugs for the treatment of retinal disease
Owner
- Outlook Therapeutics, Inc., Iselin, NJ, US
- Outlook Therapeutics, Inc., Iselin, NJ, US
Prosecution history
- 13 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Mar 2026 — SOU EXTENSION 5 GRANTED
- 14 Oct 2025 — SOU EXTENSION 5 FILED
- 12 Mar 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 14 Oct 2025 — SOU TEAS EXTENSION RECEIVED
- 11 Apr 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 Apr 2025 — SOU EXTENSION 4 GRANTED
- 10 Apr 2025 — SOU EXTENSION 4 FILED
- 10 Apr 2025 — SOU TEAS EXTENSION RECEIVED
- 19 Mar 2025 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 19 Mar 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 19 Mar 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 19 Mar 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 03 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 Dec 2024 — SOU EXTENSION 3 GRANTED